Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue.
Net income attributable to shareholders was $72 million or $0.04 per share in the December quarter, compared to $1.76 billion or $0.87 per share in the comparable period of 2023. Adjusted profit dropped to $1.67 per share in Q4 from $1.70 per share in the prior year period.
Fourth-quarter revenues increased 8% from last year to $12.3 billion. Domestic revenues rose 9% and international revenues moved up 5%.
Prior Performance
The post Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report first appeared on AlphaStreet.
Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue. Net income attributable to shareholders was $72 million or
The post Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report first appeared on AlphaStreet.
Categories AlphaGraphs, Earnings, Health Care
Highlights of Bristol-Myers Squibb’s Q4 2024 earnings report
Biotechnology company Bristol Myers Squibb (NYSE: BMY) reported lower profit for the fourth quarter of 2024, despite an increase in revenue.
Net income attributable to shareholders was $72 million or $0.04 per share in the December quarter, compared to $1.76 billion or $0.87 per share in the comparable period of 2023. Adjusted profit dropped to $1.67 per share in Q4 from $1.70 per share in the prior year period.
Fourth-quarter revenues increased 8% from last year to $12.3 billion. Domestic revenues rose 9% and international revenues moved up 5%.
Prior Performance
Listen to the conference calls as they happen. Don’t miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Coca-Cola (KO) looks poised to end fiscal 2024 on a mixed note
The Coca-Cola Company (NYSE: KO) has an impressive track record of effectively navigating market headwinds by continually innovating its product portfolio to align with customers’ changing consumption patterns. While the
Take-Two (TTWO) expects strength in NBA 2K and softness in mobile to continue in 4Q25
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) soared 14% on Friday. The company delivered mixed results for the third quarter of 2025, as revenue came below estimates while loss
EXPE Earnings: Expedia reports higher revenue and profit for Q4 2024
Expedia Group, Inc. (NASDAQ: EXPE) has reported a double-digit growth in revenues and adjusted earnings for the fourth quarter of 2024. The travel company’s gross bookings rose 13% during the
Tags